13F Filings History of Context Capital Management, LLC

Latest 13F filing
Q2 2026 - 23 Jul 2026
Latest reported 13F value
$4,956,124,817
13F snapshot Latest parsed holdings, value, and filing-period context. 2 signals
Form 13F summary
  • Context Capital Management, LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
  • Form 13F is generally due within 45 days after each calendar quarter ends.
  • Context Capital Management, LLC reported 423 equity holdings with a total reported market value of $4,956,124,817 for Q2 2026. Top reported holdings included ECHOSTAR CORP, MAKEMYTRIP LIMITED MAURITIUS, GAMESTOP CORP, SUPER MICRO COMPUTER INC, and ENOVIS CORPORATION.
Largest 13F holdings
ECHOSTAR CORP MAKEMYTRIP LIMITED MAURITIUS GAMESTOP CORP SUPER MICRO COMPUTER INC ENOVIS CORPORATION MARA HOLDINGS INC PELOTON INTERACTIVE INC TELADOC HEALTH INC STRATEGY INC RIVIAN AUTOMOTIVE INC GOOGM SNAP INC
+7 moreAPPLIED DIGITAL CORP PACIRA BIOSCIENCES INC GOOGN CENTURY ALUM CO AMPHASTAR PHARMACEUTICALS IN SMCIP JOBY AVIATION INC
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
Grace Brescia - Director of Compliance
Manager location
Lajolla, CA

Follow Filing Activity

Follow Context Capital Management, LLC with Pro and return when a new 13F portfolio filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Review Pro alert access Already have an account? Sign in and return here
Holdings Value

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter
Q2 2026
Latest value
$4,956,124,817
Quarter delta
+$629,325,417
Accepted
23 Jul 2026, 10:21
Rows shown
1-25 of 47
Quarter Holdings SEC-reported value Bought Sold Net Top Holdings Form Type Accepted by SEC
Q2 2026 423 $4,956,124,817 +$1,719,983,622 -$1,327,994,889 +$391,988,733 ECHOSTAR CORP, MAKEMYTRIP LIMITED MAURITIUS, GAMESTOP CORP, SUPER MICRO COMPUTER INC, ENOVIS CORPORATION 13F-HR 23 Jul 2026, 10:21
Q1 2026 392 $4,326,799,400 +$1,301,495,341 -$797,594,415 +$503,900,926 STRATEGY INC, ECHOSTAR CORP, CENTURY ALUM CO, CONMED CORP, TELADOC HEALTH INC 13F-HR 07 May 2026, 15:23
Q4 2025 327 $3,880,974,285 +$3,651,519,532 -$504,727,292 +$3,146,792,240 STRATEGY INC, ECHOSTAR CORP, PELOTON INTERACTIVE INC, MARA HOLDINGS INC, CONMED CORP 13F-HR 13 Feb 2026, 15:33
Q3 2025 267 $1,474,664,860 +$579,522,424 -$571,103,236 +$8,419,188 ECHOSTAR CORP, EQUINOX GOLD CORP, GROUPON INC, IMMUNOCORE HLDGS PLC, CENTURY ALUM CO 13F-HR 12 Nov 2025, 14:53
Q2 2025 251 $1,958,086,820 +$691,521,140 -$415,543,932 +$275,977,208 PELOTON INTERACTIVE INC, PACIRA BIOSCIENCES INC, IMMUNOCORE HLDGS PLC, BRIDGEBIO PHARMA INC, SOLAREDGE TECHNOLOGIES INC 13F-HR 06 Aug 2025, 10:02
Q1 2025 208 $1,507,524,418 +$421,688,957 -$319,920,154 +$101,768,803 3D SYS CORP DEL, GROUPON INC, EQUINOX GOLD CORP, SOLAREDGE TECHNOLOGIES INC, COHERUS BIOSCIENCES INC 13F-HR 05 May 2025, 11:37
Q4 2024 238 $1,250,669,439 +$391,745,681 -$1,398,542,768 -$1,006,797,087 3D SYS CORP DEL, REVANCE THERAPEUTICS INC, COHERUS BIOSCIENCES INC, ALPHATEC HLDGS INC, GROUPON INC 13F-HR 11 Feb 2025, 10:47
Q3 2024 284 $1,779,522,739 +$774,694,345 -$183,564,044 +$591,130,301 ROCKETLAB USA INC, PELOTON INTERACTIVE INC, NEXTERA ENERGY PARTNERS LP, BEAUTY HEALTH CO, ALPHATEC HLDGS INC 13F-HR 14 Nov 2024, 14:47
Q2 2024 222 $1,503,792,085 +$650,098,079 -$292,100,763 +$357,997,316 THE BEAUTY HEALTH COMPANY, 3D SYS CORP DEL, NEXTERA ENERGY PARTNERS LP, ESPERION THERAPEUTICS INC NE, ALPHATEC HLDGS INC 13F-HR 09 Aug 2024, 15:21
Q1 2024 277 $1,594,261,483 +$408,396,283 -$1,070,885,961,578 -$1,070,477,565,295 BEAUTY HEALTH CO, PELOTON INTERACTIVE INC, MICROSTRATEGY INC, 3D SYS CORP DEL, ALPHATEC HLDGS INC 13F-HR 02 May 2024, 15:51
Q4 2023 281 $1,488,903,696 +$1,462,894,382 -$113,967,336 +$1,348,927,046 PELOTON INTERACTIVE INC, WAYFAIR INC, WAYFAIR INC, COINBASE GLOBAL INC, MICROSTRATEGY INC Restatement 16 Feb 2024, 17:02
Q3 2023 301 $457,434,743 +$86,492,013 -$52,135,136 +$34,356,877 OMEROS CORP, TRAVERE THERAPEUTICS INC, MANNKIND CORP, INTERCEPT PHARMACEUTICALS IN, ACCOLADE INC 13F-HR 13 Nov 2023, 09:40
Q2 2023 311 $400,265,887 +$46,611,669 -$185,386,005 -$138,774,336 MICROSTRATEGY INC, OMEROS CORP, ACCOLADE INC, MANNKIND CORP, ARTIVION INC 13F-HR 10 Aug 2023, 16:51
Q1 2023 340 $717,232,280 +$207,187,415 -$371,188,041 -$164,000,626 OMEROS CORP, NIO INC, MICROSTRATEGY INC, ACCOLADE INC, BLOCK INC 13F-HR 08 May 2023, 14:38
Q4 2022 440 $438,598,359 +$73,014,354 -$371,772,621 -$298,758,267 INTERCEPT PHARMACEUTICALS IN, ARTIVION INC, GSRM, CVII, KARYOPHARM THERAPEUTICS INC 13F-HR 14 Feb 2023, 09:31
Q3 2022 587 $1,126,636,705 +$223,663,902 -$206,001,551 +$17,662,351 PELOTON INTERACTIVE INC, LIVEPERSON INC, PEGASYSTEMS INC, INFINERA CORP, VAREX IMAGING CORP 13F-HR 07 Nov 2022, 13:34
Q2 2022 619 $1,212,866,240 +$249,419,784 -$321,819,235 -$72,399,451 THERAVANCE BIOPHARMA INC, INFINERA CORP, VAREX IMAGING CORP, MANNKIND CORP, LIVEPERSON INC 13F-HR 03 Aug 2022, 13:22
Q1 2022 687 $1,292,421,581 +$849,488,638 -$657,098,635 +$192,390,003 THERAVANCE BIOPHARMA INC, VAREX IMAGING CORP, INFINERA CORP, BLOOM ENERGY CORP, OMEROS CORP 13F-HR 09 May 2022, 16:12
Q4 2021 554 $979,600,976 +$537,447,094 -$293,863,283 +$243,583,811 VAREX IMAGING CORP, THERAVANCE BIOPHARMA INC, BLOOM ENERGY CORP, OMEROS CORP, TWO HARBORS INVENTMENT CORPO 13F-HR 09 Feb 2022, 14:26
Q3 2021 472 $705,646,078 +$233,036,902 -$197,031,898 +$36,005,004 VAREX IMAGING CORP, DWACU, VEONEER INC, TWO HBRS INVT CORP, EVENTBRITE INC 13F-HR 12 Nov 2021, 10:32
Q2 2021 520 $520,319,630 +$110,990,584 -$114,717,675 -$3,727,091 NIO INC, CFIVU, AQNU, CVIIU, GIG 13F-HR 16 Aug 2021, 18:54
Q1 2021 462 $530,785,019 +$381,658,321 -$35,547,876,184 -$35,166,217,863 SEA LTD, SEACOR HOLDINGS INC, NANTHEALTH INC, NIO INC, CFIVU 13F-HR 17 May 2021, 11:07
Q4 2020 260 $727,653,550 +$455,450,415 -$215,994,299 +$239,456,116 8X8 INC NEW, INFINERA CORPORATION, GRANITE CONSTR INC, FLEXION THERAPEUTICS INC, PRA GROUP INC 13F-HR 12 Feb 2021, 14:40
Q3 2020 164 $448,322,000 +$304,826,840 -$123,426,883 +$181,399,957 8X8 INC NEW, SEA LTD, VEONEER INCORPORATED, INTERCEPT PHARMACEUTICALS IN, AMAG PHARMACEUTICALS INC 13F-HR 16 Nov 2020, 16:47
Q2 2020 103 $254,940,000 +$96,009,901 -$61,608,717 +$34,401,184 INOVIO PHARMACEUTICALS INC, OPKO HEALTH INC, INTERCEPT PHARMACEUTICALS IN, CYTOKINETICS INC, SEA LTD 13F-HR 11 Aug 2020, 15:53
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .